High Note Wealth’s ANI Pharmaceuticals ANIP Stock Holding History

High Note Wealth’s Portfolio ANIP Stock Details ANIP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-5,802	Closed	-$379K	–	876
2025 Q2	$379K	Hold	5,802	–	–	0.09%	85
2025 Q1	$388K	Hold	5,802	–	–	0.1%	74
2024 Q4	$321K	Hold	5,802	–	–	0.08%	83
2024 Q3	$346K	Hold	5,802	–	–	0.1%	81
2024 Q2	$369K	Hold	5,802	–	–	0.11%	77
2024 Q1	$401K	Hold	5,802	–	–	0.13%	73
2023 Q4	$320K	Hold	5,802	–	–	0.12%	74
2023 Q3	$337K	Hold	5,802	–	–	0.14%	75
2023 Q2	$312K	Hold	5,802	–	–	0.13%	76
2023 Q1	$230K	Hold	5,802	–	–	0.1%	91
2022 Q4	$233K	Hold	5,802	–	–	0.1%	84
2022 Q3	$221K	Buy	+5,802	New	+$199K	0.09%	89
2022 Q1	–	Sell	-5,802	Closed	-$267K	–	91
2021 Q4	$267K	Buy	+5,802	New	+$249K	0.09%	76

Other funds holding ANIP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

GACM

Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

High Note Wealth's ANIP Position: Q3 2025 in Review

High Note Wealth sold out of ANI Pharmaceuticals (ANIP) in Q3 2025, closing a stake of 5,802 shares — an estimated $379K sold.

High Note Wealth first reported a position in ANIP in Q4 2021 and held it in 13 quarters. The position peaked at $401K in Q1 2024. 269 funds tracked by Wall St. Rank hold ANIP as of Q3 2025.

High Note Wealth reported no remaining ANI Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
High Note Wealth sold 5,802 ANI Pharmaceuticals shares in Q3 2025, an estimated $379K.
High Note Wealth first reported a position in ANI Pharmaceuticals in Q4 2021 and held it in 13 quarters.
High Note Wealth's ANI Pharmaceuticals position peaked at $401K in Q1 2024.
269 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q3 2025.

Based on High Note Wealth's 13F filing for Q3 2025, filed 4 Nov 2025.